Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis of glomeruli and kidney cortex following podocyte-loss of Klf4

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE149819 | GEO | 2021/09/22

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptomic analysis of kidney cortex following podocyte-loss of Klf4

Project description:The goal of this study was to identify transcriptomic changes of mouse kidney cortex in mice with podocyte-specific deletion of Kruppel-like factor 4, a zinc-finger transcription factor.

2021-09-22 | GSE149818 | GEO

Transcriptomic analysis of glomeruli following podocyte-loss of Klf4

Project description:The goal of this study was to identify transcriptomic changes of mouse glomeruli in mice with podocyte-specific deletion of Kruppel-like factor 4, a zinc-finger transcription factor.

2021-09-22 | GSE149817 | GEO

Transcriptomic analysis of glomeruli and kidney cortex following podocyte-loss of Klf4

Project description:Transcriptomic analysis of glomeruli and kidney cortex following podocyte-loss of Klf4

| PRJNA630225 | ENA

Transcriptomic analysis of kidney cortex following podocyte-loss of Klf4

Project description:Transcriptomic analysis of kidney cortex following podocyte-loss of Klf4

| PRJNA630232 | ENA

Transcriptomic analysis of glomeruli following podocyte-loss of Klf4

Project description:Transcriptomic analysis of glomeruli following podocyte-loss of Klf4

| PRJNA630231 | ENA

Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Project description:Podocyte depletion is a major mechanism driving glomerulosclerosis. Progression is the process by which progressive glomerulosclerosis leads to end stage kidney disease (ESKD). In order to determine mechanisms contributing to persistent podocyte loss, we used a human diphtheria toxin transgenic rat model. After initial diphtheria toxin-induced podocyte injury (over 30% loss in 4 weeks), glomeruli became destabilized, resulting in continued autonomous podocyte loss causing global podocyte depletion (ESKD) by 13 weeks. This was monitored by urine mRNA analysis and by quantitating podocytes in glomeruli. Similar patterns of podocyte depletion were found in the puromycin aminonucleoside and 5/6 nephrectomy rat models of progressive end-stage disease. Angiotensin II blockade (combined enalapril and losartan) restabilized the glomeruli, and prevented continuous podocyte loss and progression to ESKD. Discontinuing angiotensin II blockade resulted in recurrent glomerular destabilization, podocyte loss, and progression to ESKD. Reduction in blood pressure alone did not reduce proteinuria or prevent podocyte loss from destabilized glomeruli. The protective effect of angiotensin II blockade was entirely accounted for by reduced podocyte loss. Thus, an initiating event resulting in a critical degree of podocyte depletion can destabilize glomeruli and initiate a superimposed angiotensin II-dependent podocyte loss process that accelerates progression resulting in eventual global podocyte depletion and ESKD. These events can be monitored noninvasively in real-time through urine mRNA assays.

| S-EPMC3739490 | biostudies-literature

Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.

Project description:Podocyte depletion is a common mechanism driving progression in glomerular diseases. Alport Syndrome glomerulopathy, caused by defective α3α4α5 (IV) collagen heterotrimer production by podocytes, is associated with an increased rate of podocyte detachment detectable in urine and reduced glomerular podocyte number suggesting that defective podocyte adherence to the glomerular basement membrane might play a role in driving progression. Here a genetically phenotyped Alport Syndrome cohort of 95 individuals [urine study] and 41 archived biopsies [biopsy study] were used to test this hypothesis. Podocyte detachment rate (measured by podocin mRNA in urine pellets expressed either per creatinine or 24-hour excretion) was significantly increased 11-fold above control, and prior to a detectably increased proteinuria or microalbuminuria. In parallel, Alport Syndrome glomeruli lose an average 26 podocytes per year versus control glomeruli that lose 2.3 podocytes per year, an 11-fold difference corresponding to the increased urine podocyte detachment rate. Podocyte number per glomerulus in Alport Syndrome biopsies is projected to be normal at birth (558/glomerulus) but accelerated podocyte loss was projected to cause end-stage kidney disease by about 22 years. Biopsy data from two independent cohorts showed a similar estimated glomerular podocyte loss rate comparable to the measured 11-fold increase in podocyte detachment rate. Reduction in podocyte number and density in biopsies correlated with proteinuria, glomerulosclerosis, and reduced renal function. Thus, the podocyte detachment rate appears to be increased from birth in Alport Syndrome, drives the progression process, and could potentially help predict time to end-stage kidney disease and response to treatment.

| S-EPMC5696060 | biostudies-literature

Transcriptomic analysis of kidney cortex following the loss of functional Sco2

Project description:The goal of this study was to identify transcriptomic changes caused by loss of functional Sco2 in kidney cortex of db/db mice (Type II Diabetes Mellitus mouse model).

2022-01-26 | GSE171722 | GEO

Podocyte-specific KLF4 is required to maintain parietal epithelial cell quiescence in the kidney.

Project description:[Figure: see text].

| S-EPMC8442927 | biostudies-literature

Transcriptomic analysis of kidney cortex following the loss of functional Sco2

Project description:Transcriptomic analysis of kidney cortex following the loss of functional Sco2

| PRJNA720659 | ENA